---
figid: PMC8897051__gr2
figtitle: 'Repurposing non-oncology small-molecule drugs to improve cancer therapy:
  Current situation and future directions'
organisms:
- NA
pmcid: PMC8897051
filename: gr2.jpg
figlink: /pmc/articles/PMC8897051/figure/fig2/
number: F2
caption: The relevant signaling pathways of repurposing drugs in cancer therapy. The
  first one is JAK/STAT3 pathway for chloroquine, artemisinin, daraprim, benztropine
  and auranofin; RAS/RAF/ERK pathway for Digoxin, simvastatin, mevastatin, fluvastatin,
  nelfinavir, mebendazole, niclosamide; PI3K/AKT/mTOR pathway for prazosin, chloroquine,
  artemisinin, itraconazole, AM404, albendazole, ritonavir; and WNT/β-catenin pathways
  for asprine, benztropine, mebendazole, niclosamide.
papertitle: 'Repurposing non-oncology small-molecule drugs to improve cancer therapy:
  Current situation and future directions.'
reftext: Leilei Fu, et al. Acta Pharm Sin B. 2022 Feb;12(2):532-557.
year: '2022'
doi: 10.1016/j.apsb.2021.09.006
journal_title: Acta Pharmaceutica Sinica. B
journal_nlm_ta: Acta Pharm Sin B
publisher_name: Elsevier
keywords: Drug repurposing | Non-oncology drug | Cancer therapy | Cardiovascular drug
  | Microbiological drug | Small-molecule antibiotics | Anti-viral drug | Anti-inflammatory
  drug
automl_pathway: 0.9391955
figid_alias: PMC8897051__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8897051__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8897051__gr2.html
  '@type': Dataset
  description: The relevant signaling pathways of repurposing drugs in cancer therapy.
    The first one is JAK/STAT3 pathway for chloroquine, artemisinin, daraprim, benztropine
    and auranofin; RAS/RAF/ERK pathway for Digoxin, simvastatin, mevastatin, fluvastatin,
    nelfinavir, mebendazole, niclosamide; PI3K/AKT/mTOR pathway for prazosin, chloroquine,
    artemisinin, itraconazole, AM404, albendazole, ritonavir; and WNT/β-catenin pathways
    for asprine, benztropine, mebendazole, niclosamide.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - hop
  - bsk
  - Raf
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Mtor
  - Tor
  - Akt
  - p53
  - betaTub60D
  - hth
  - Jra
  - arm
  - pan
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - sgg
  - Axn
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MTG1
  - STAT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - KRAS
  - HRAS
  - NRAS
  - MAPK8
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - MDM2
  - MDM4
  - TP53
  - TP63
  - TP73
  - JUN
  - CTNNB1
  - HNF4A
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GSK3A
  - GSK3B
  - AXIN1
  - AXIN2
---
